← All stocks

Artiva Biotherapeutics, Inc.

ARTV Net buying

CIK 0001817241 #3037 in the set updated 17 Sep 2026

Bought (120 mo)

$274.12M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.01M

$518.97K on a plan · $103.88K straight out of an exercise

Sold at will

$1.39M

9 of 16 sales

Net

+$272.11M

+$272.73M against sales at will

By person

15 insiders · 45 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$192.62M (21)

—

+$192.62M

17,329,570

$189.17M

—

GC Corp. entity

10% owner

$41.50M (4)

—

+$41.50M

5,999,703

$65.49M

+931.9%

Huh Yong-Jun

Director

$25.00M (2)

—

+$25.00M

1,260,512

$13.76M

—

5AM Partners VI, LLC entity

10% owner

$10.00M (1)

—

+$10.00M

1,182,054

$12.90M

—

venBio Global Strategic Fund III, L.P. entity

10% owner

$5.00M (1)

—

+$5.00M

1,936,637

$21.14M

—

Aslan Fred

Chief Executive Officer

—

$1.45M (7)

−$1.45M

1,604,765

$17.52M

—

Banerjee Subhashis

Chief Medical Officer

—

$179.54K (4) scheduled

−$179.54K

170,947

$1.87M

—

Horan Christopher

Chief Tech Operations Officer

—

$178.71K (2)

−$178.71K

323,084

$3.53M

—

Bush Jennifer

COO, CLO, Compliance Officer

—

$172.78K (2)

−$172.78K

374,529

$4.09M

+1,543%

Raymon Heather

SVP, Research and Development

—

$27.88K (1)

−$27.88K

148,228

$1.62M

—

Huston Thad Allen

Chief Financial Officer

—

220,000

$2.40M

—

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

194,108

$2.12M

—

Miralles Gines Diego

President & Head of R&D

—

122,500

$1.34M

—

Krishnamohan Neha

Chief Financial Officer

—

99,356

$1.08M

—

Graef Thorsten

Chief Medical Officer

—

80,000

$873.26K

—

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 24,289,328 to 48,890,121 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Aslan Fred

3 Sep 2026

Chief Executive Officer

Sell

61,888

$11.16

$690.39K

Banerjee Subhashis

3 Sep 2026

Chief Medical Officer

Sell

1,100

$11.16

$12.27K

Bush Jennifer

3 Sep 2026

COO, CLO, Compliance Officer

Sell

8,391

$11.16

$93.61K

Horan Christopher

3 Sep 2026

Chief Tech Operations Officer

Sell

10,366

$11.16

$115.64K

Aslan Fred

19 May 2026

Chief Executive Officer

Sell

27,116

$9.01

$244.25K

Banerjee Subhashis

19 May 2026

Chief Medical Officer

Sell

7,037

$9.01

$63.39K

Bush Jennifer

19 May 2026

COO, CLO, Compliance Officer

Sell

8,790

$9.01

$79.18K

Horan Christopher

19 May 2026

Chief Tech Operations Officer

Sell

7,002

$9.01

$63.07K

Raymon Heather

19 May 2026

SVP, Research and Development

Sell

3,095

$9.01

$27.88K

Show all 45 transactions →

Artiva Biotherapeutics, Inc.

By person

Individual transactions

What was left out